Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTBP2P9 (CTBP2 pseudogene 9) is a **pseudogene** of the CTBP2 gene. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional; they typically do not encode functional proteins. CTBP2P9 does not encode an active protein and has no known physiological function, no involvement in disease, and is not relevant as a biomarker or therapeutic target. Its only relevance is as a sequence related to **C-terminal binding protein 2 (CTBP2)**, a functional gene that acts as a transcriptional corepressor, but CTBP2P9 itself plays no biological role. [8] If you require information about the functional gene and protein (C-terminal binding protein 2, CTBP2), please specify. CTBP2 itself is involved in transcriptional regulation, metabolism sensing, and cancer biology, but CTBP2P9 as a pseudogene does not share these functions.
null (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTBP2 pseudogene 9 (CTBP2P9).